TG Therapeutics completes $100 million buyback, authorizes new program
Tweet Send to a Friend
TG Therapeutics Inc. (NASDAQ: TGTX) completed its $100 million share repurchase program and authorized a new $100 million buyback program ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
